This control plane turns synthetic assay-release exports into one review surface: batch evidence continuity, stale calibration artifacts, stability bridges, analytical variance, and final release-packet completeness before downstream handoff.
Biotech teams need one board where batch evidence, calibration freshness, stability proof, analytical variance, and final signoff stay readable together.
This fits the Kinetic Gain pattern: routing, evidence, approvals, and operator-safe remediation posture for release-critical work.
The free surface proves the operator model; the commercial path is an embedded release-readiness module for regulated assay workflows.